Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Jupiter Neurosciences (JUNS) Long-Term Debt Issuances (2024)

Jupiter Neurosciences (JUNS) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $1500.0 as the latest value for Q4 2024.

  • Quarterly Long-Term Debt Issuances changed N/A to $1500.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $138500.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $5.6 million for FY2025, 3928.88% up from the prior year.
  • Long-Term Debt Issuances for Q4 2024 was $1500.0 at Jupiter Neurosciences, down from $28000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $64000.0 in Q2 2024, with the low at $1500.0 in Q4 2024.